0001831601-24-000002.txt : 20240304 0001831601-24-000002.hdr.sgml : 20240304 20240304094453 ACCESSION NUMBER: 0001831601-24-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240304 DATE AS OF CHANGE: 20240304 EFFECTIVENESS DATE: 20240304 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Focal Medical, Inc. CENTRAL INDEX KEY: 0001831601 ORGANIZATION NAME: IRS NUMBER: 471550292 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-506572 FILM NUMBER: 24713081 BUSINESS ADDRESS: STREET 1: 2301 STONEHENGE DRIVE STREET 2: SUITE 204 CITY: RALEIGH STATE: NC ZIP: 27615 BUSINESS PHONE: 919-917-7324 MAIL ADDRESS: STREET 1: 2301 STONEHENGE DRIVE STREET 2: SUITE 204 CITY: RALEIGH STATE: NC ZIP: 27615 FORMER COMPANY: FORMER CONFORMED NAME: Advanced Chemotherapy Technologies, Inc. DATE OF NAME CHANGE: 20201106 D 1 primary_doc.xml X0708 D LIVE 0001831601 Focal Medical, Inc. 111 James Jackson Avenue SUITE 131 Cary NC NORTH CAROLINA 27513 919-917-7324 DELAWARE Advanced Chemotherapy Technologies, Inc. Corporation true Michael Aldridge 111 James Jackson Avenue Suite 131 Cary NC NORTH CAROLINA 27513 Executive Officer Director Jen Jen Yeh 111 James Jackson Avenue Suite 131 Cary NC NORTH CAROLINA 27513 Director Joseph DeSimone 111 James Jackson Avenue Suite 131 Cary NC NORTH CAROLINA 27513 Director Nessan Bermingham 111 James Jackson Avenue Suite 131 Cary NC NORTH CAROLINA 27513 Director Biotechnology Decline to Disclose 06b false 2024-02-21 false true false 0 950000 950000 0 false 2 0 0 0 true Proceeds will be used for working capital, which may include normal compensation to executive officers. false Focal Medical, Inc. Michael Aldridge Michael Aldridge CEO 2024-03-01